Rationale for the use of antioxidant vitamins in clinical organ transplantation

Transplantation

Volumn 62, Issue 9, 1996, Pages 1197-1199

  Lehr, Hans Anton ^a   Messmer, Konrad ^b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CAROTENE; CREATININE; DNA; FATTY ACID; GLUTATHIONE; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; LIPID; LYCOPENE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MALONALDEHYDE; MONOCLONAL ANTIBODY; OXYGEN; PROTEIN; PROTEINASE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; VITAMIN;

ATHEROSCLEROSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; ISCHEMIA; LEUKOCYTE; LIPID PEROXIDATION; NONHUMAN; ORGAN DONOR; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW;

ANTIOXIDANTS; HUMANS; ORGAN TRANSPLANTATION; REACTIVE OXYGEN SPECIES; REPERFUSION INJURY;

EID: 0030479298     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199611150-00001     Document Type: Review

References (47)

1. Cosimi AB, Conti D, Delmonico FL, et al. In vivo effects of monoclonal antibody to ICAM-1 (CD54) in nonhuman primates with renal allografts. J Immunol 1990; 144: 4604.
2. Isobe M, Yagita H, Okumura K, Ihara A. Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1. Science 1992; 255: 1125.
3. Granger DN, Benoit JN, Suzuki M, Grisham MB. Leukocyte adherence to venular endothelium during ischemia-reperfusion. Am J Physiol 1989; 257: G683.
4. Granger DN, Kubes P. The microcirculation and inflammation: modulation of leukocyte/endothelial cell adhesion. J Leukoc Biol 1994; 55: 662.
5. Haug CE, Colvin RB, Delmonico FL, et al. A phase I trial on immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients. Transplantation 1993; 55: 766.
6. Menger MD, Lehr HA, Messmer K. Role of oxygen radicals in the microcirculatory manifestations of ischemia/reperfusion injury. Klin Wochenschr 1991; 69: 1050.
7. Halliwell B. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 1994; 344: 721.
8. Rao PN, Walsh TR, Makowka L, et al. Inhibition of free radical generation and improved survival by protection of the hepatic microvascular endothelium by targeted erythrocytes in orthotopic liver transplantation. Transplantation 1990; 49: 1055.
9. Oda T, Nakai I, Mituo M, Yamagishi H, Oka T, Yoshikawa T. Role of oxygen radicals and synergistic effect of superoxide dismutase and catalase on ischemia-reperfusion injury of the rat pancreas. Transplant Proc 1992; 24: 797.
10. Demirbas A, Bozoklu S, Özdemir A, Bilgin N, Haberal M. Effect of alpha tocopherol on the prevention of reperfusion injury caused by free oxygen radicals in the canine kidney autotransplantation model. Transplant Proc 1993; 25: 2274.
11. Ikeda M, Sumimoto K, Urushihara T, Fukuda Y, Dohi K, Kawasaki T. Prevention of ischemic damage in rat pancreatic transplantation by pretreatment with alpha tocopherol. Transplant Proc 1994; 26: 561.
12. Rabl H, Khoschsorur G, Colombo T, et al. A multivitamin infusion prevents lipid peroxidation and improves transplantation performance. Kidney Int 1993; 43: 912.
13. Princemail J, Defraigne JO, Franssen C, et al. Evidence for free radical formation during human kidney transplantation. Free Radic Biol Med 1993; 15: 343.
14. Land W, Schneeberger H, Schleibner S, et al. The beneficial effect of human recombinant superoxide dismutase on acute and chronic rejection events in recipients of cadaveric renal transplants. Transplantation 1994; 57: 211.
15. Goode HF, Webster NR, Howdle PD, et al. Reperfusion injury, antioxidants and hemodynamics during orthotopic liver transplantation. Hepatology 1994; 19: 354.
16. Davenport A, Hopton M, Bolton C. Measurement of malondialdehyde as a marker of oxygen free radical production during renal allograft transplantation and the effect of early graft function. Clin Transplant 1995; 9: 171.
17. Biasi F, Bosco M, Chiappino I, et al. Oxidative damage in human liver transplantation. Free Radic Biol Med 1995; 19: 311.
18. Galley HF, Richardson N, Howdle PD, Walker BE, Webster NR. Total antioxidant capacity and lipid peroxidation during liver transplantation. Clin Sci 1995; 89: 329.
19. Hower R, Minor TH, Schneeberger H, et al. Assessment of oxygen radicals during human kidney transplantation: effect of radical scavenger. Transpl Int (in press).
20. Slakey D, Roza A, Pieper G, Johnson C, Adams M. Ascorbic acid and alpha tocopherol prolong rat cardiac allograft survival. Transplant Proc 1993; 25: 610.
21. Shackleton CR, Ettinger SL, McLoughlin MC, Scudamore CH, Miller RR, Keown PA. Effect of recovery from ischemia injury on class I and class II MHC antigen expression. Transplantation 1990; 49: 641.
22. Shoskes DA, Parfrey NA, Halloran PF. Increased major histocompatibility complex antigen expression in unilateral ischemia acute tubular necrosis in the mouse. Transplantation 1990; 49: 201.
23. Adoumie R, Serrick C, Giaid A, Shennib H. Early cellular events in the lung allograft. Ann Thor Surg 1992; 54: 1071.
24. Bishop GA, Waugh JA, Hall BM. Expression of HLA antigens on renal tubular cells in culture: II. Effect of increased HLA antigen expression on tubular cell stimulation of lymphocyte activation and on their vulnerability to cell-mediated lysis. Transplantation 1988; 46: 303.
25. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxy nitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990; 87: 1620.
26. Dusting GJ. Nitric oxide in cardiovascular disorders. J Vasc Res 1995; 32: 143.
27. Kubes P, Kanwar S, Niu XF, Gaboury J. Nitric oxide synthesis inhibition induces leukocyte adhesion via superoxide and mast cells. FASEB J 1993; 7: 1293.
28. Langrehr JM, Hoffman RA, Lancaster JR, Simmons RL. Nitric oxide - a new endogenous immunomodulator. Transplantation 1993; 55: 1205.
29. Mills GD. Molecular basis of "suppressor" macrophages. Arginine metabolism via the nitric oxide synthase pathway. J Immunol 1991; 146: 2719.
30. Land W, Messmer. The impact of ischemia/reperfusion injury on specific and non-specific, early and late chronic events after organ transplantation. Transplant Rev 1996; 10: 108.
31. Häyry P, Isoniemi H, Yilmaz S, et al. Chronic allograft rejection. Immunol Rev 1993; 134: 33.
32. Azuma H, Tilney NL. Chronic graft rejection. Curr Opin Immunol 1994; 6: 770.
33. Fellström B. Vascular mechanisms in the development of chronic rejection. Prog Appl Microcirc 1995; 21: 92.
34. Duijvestijn A, Kok M, Miyasaka M, Vriesman PV. ICAM-1 and LFA-1/CD18 expression in chronic renal allograft rejection. Transplant Proc 1993; 25: 2867.
35. Vender RL, Clemmons DR, Kwock L, Friedman M. Reduced oxygen tension induces pulmonary endothelium to release pulmonary smooth muscle cell mitogen(s). Am Rev Respir Dis 1987; 135: 622.
36. Hassoun PM, Pasricha PJ, Teufel E, Lee SL, Fanburg BL. Hypoxia stimulates the release by bovine pulmonary artery endothelial cells of an inhibitor of pulmonary artery smooth muscle cell growth. Am J Respir Cell Mol Biol 1989; 1: 377.
37. Rao GN, Berk BC. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression. Circ Res 1992; 70: 593.
38. Michiels C, De Leener F, Arnould T, Dieu M, Remacle J. Hypoxia stimulates human endothelial cells to release smooth muscle cell mitogens: role of prostaglandins and bFGF. Exp Cell Res 1994; 213: 43.
39. Yilmaz S, Paavonen T, Häyry P. Chronic rejection of rat kidney allografts: II. The impact of prolonged ischemia on transplant histology. Transplantation 1992; 53: 823.
40. Wanders A, Akyürek MI, Waltenberger J, et al. Ischemia-induced transplant arteriosclerosis in the rat. Arterioscler Thromb Vasc Biol 1995; 15: 145.
41. Gaudin PB, Rayburn BK, Hutchins GM, et al. Peritransplant injury to the myocardium associated with the development of accelerated arteriosclerosis in heart transplant recipients. Am J Surg Pathol 1994; 18: 338.
42. Enstrom JE, Kanim LE, Klein MA. Vitamin C intake and mortality among a sample of the United States population. Epidemiology 1992; 3: 194.
43. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Michinson MJ. Randomized controlled trial of vitamin E in patients with coronary disease: Cambridge heart antioxidant study (CHAOS). Lancet 1996; 346: 781.
44. Diplock AT. Safety of antioxidant vitamins and β-carotene. Am J Clin Nutr 1995; 62: 1510S.
45. Frei B, England L, Ames BN. Ascobate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci USA 1989; 86: 6377.
46. Cavarocchi NC, England MD, O'Brien JF, et al. Superoxide generation during cardiopulmonary bypass: is there a role for vitamin E? J Surg Res 1986; 40: 519.
47. Eddy L, Hurvitz R, Hochstein P. A protective role for ascorbate in induced ischemic arrest associated with cardiopulmonary bypass. J Appl Cardiol 1990; 5: 409.